Literature DB >> 8140621

Role of the beta-amyloid precursor protein in Alzheimer's disease.

F Ashall1, A M Goate.   

Abstract

Deposition of beta-amyloid peptide in the brain is an early event in Alzheimer's disease, the most common cause of dementia. Studies of the beta-amyloid precursor protein (APP), which gives rise to beta-amyloid, are rapidly leading to a better understanding of the biochemical basis of the disease--a prerequisite for rational drug development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8140621     DOI: 10.1016/0968-0004(94)90173-2

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  17 in total

1.  Immunization against Alzheimer's beta -amyloid plaques via EFRH phage administration.

Authors:  D Frenkel; O Katz; B Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

2.  Humanin improves impaired metabolic activity and prolongs survival of serum-deprived human lymphocytes.

Authors:  Shingo Kariya; Nobuyuki Takahashi; Makito Hirano; Satoshi Ueno
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

3.  Hypomethylation of the amyloid precursor protein gene in the brain of an Alzheimer's disease patient.

Authors:  R L West; J M Lee; L E Maroun
Journal:  J Mol Neurosci       Date:  1995       Impact factor: 3.444

Review 4.  The role of beta-amyloid in the development of Alzheimer's disease.

Authors:  K Ii
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923

5.  Amyloid beta peptide processing, insulin degrading enzyme, and butyrylcholinesterase.

Authors:  A S Balasubramanian
Journal:  Neurochem Res       Date:  2001-04       Impact factor: 3.996

Review 6.  Alzheimer's disease: fundamental and therapeutic aspects.

Authors:  M Schorderet
Journal:  Experientia       Date:  1995-02-15

7.  Residues in the synuclein consensus motif of the alpha-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid beta A4 peptide.

Authors:  P H Jensen; E S Sørensen; T E Petersen; J Gliemann; L K Rasmussen
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

Review 8.  Lipid rafts in neurodegeneration and neuroprotection.

Authors:  Sandro Sonnino; Massimo Aureli; Sara Grassi; Laura Mauri; Simona Prioni; Alessandro Prinetti
Journal:  Mol Neurobiol       Date:  2013-12-22       Impact factor: 5.590

9.  Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.

Authors:  C R Harrington; J Louwagie; R Rossau; E Vanmechelen; R H Perry; E K Perry; J H Xuereb; M Roth; C M Wischik
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

Review 10.  Disturbances in signal transduction mechanisms in Alzheimer's disease.

Authors:  C J Fowler; R F Cowburn; A Garlind; B Winblad; C O'Neill
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.